NCLAT: IRP Has Authority to Take Possession of Assets Owned by Corporate Debtor || NCLAT: NCLT Can Direct Forwarding a Copy of its Order to Relevant Statutory Authorities || Delhi HC: Centre to Expedite Process of Accessibility Features in OTT platforms for PwDs || Delhi HC: Once Worker Provides Testimony Under Oath ‘Burden of Proof’ Shifts on Employer || SC: There Cannot be Discrimination in Matter of Payment of Pension to Retired Judges || SC: India is Not a Dharamshala that Can Entertain Foreign Nationals from All Over || SC: Can Quash Domestic Violence Act Complaints Under Section 482 of CrPC || Supreme Court: Can’t Use Statement of One Accused against Another || SC: Inclusion of Name in Draft NRC Cannot Annul Foreigners Tribunal’s Declaration as Non-Citizen || Supreme Court: Minimum Practice of 3 Years Mandatory to Enter Judicial Service

DGFT Changes Export Policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients - (15 Jun 2021)

CIVIL

Director-General of Foreign Trade (DGFT) has notified the changes in the Export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients from ‘Prohibited’ to ‘Restricted’. Further, export of Injection Remdesivir and Remdesivir API against Advance Authorizations issued under Chapter 4 of Foreign Trade Policy/Handbook of Procedures shall not require separate export authorization or permission.

Tags : DIRECTOR-GENERAL OF FOREIGN TRADE EXPORT POLICY OF INJECTION REMDESIVIR AND REMDESIVIR ACTIVE PHARMACEUTICAL INGREDIENTS

Share :